These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37133569)

  • 1. LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection.
    Zhang C; Yang R; Wang X; Tao Y; Tang S; Tian Z; Zhou Y
    Ann Surg Oncol; 2023 Aug; 30(8):4876-4885. PubMed ID: 37133569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI.
    Moon JY; Min JH; Kim YK; Cha D; Hwang JA; Ko SE; Choi SY; Yun EJ; Kim SW; Won HJ
    Korean J Radiol; 2021 Nov; 22(11):1786-1796. PubMed ID: 34402243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
    Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
    Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
    Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
    Chen J; Zhou J; Kuang S; Zhang Y; Xie S; He B; Deng Y; Yang H; Shan Q; Wu J; Sirlin CB; Wang J
    AJR Am J Roentgenol; 2019 Oct; 213(4):821-830. PubMed ID: 31120791
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined Hepatocellular-Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma.
    Kim DH; Choi SH; Kim DW; Lee SS; Lim YS; Kim SY; Kim HJ; Kim JH; Byun JH
    J Magn Reson Imaging; 2021 Jun; 53(6):1803-1812. PubMed ID: 33565208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Kang HJ; Kim H; Lee DH; Hur BY; Hwang YJ; Suh KS; Han JK
    Radiology; 2021 Sep; 300(3):572-582. PubMed ID: 34227881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Texture Analysis Based on Preoperative Magnetic Resonance Imaging (MRI) and Conventional MRI Features for Predicting the Early Recurrence of Single Hepatocellular Carcinoma after Hepatectomy.
    Zhang J; Liu X; Zhang H; He X; Liu Y; Zhou J; Guo D
    Acad Radiol; 2019 Sep; 26(9):1164-1173. PubMed ID: 30425000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
    Bae JS; Lee DH; Lee SM; Suh KS; Lee KW; Yi NJ; Lee KB; Kim H; Han JK
    AJR Am J Roentgenol; 2022 Jul; 219(1):86-96. PubMed ID: 35138137
    [No Abstract]   [Full Text] [Related]  

  • 10. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
    Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
    Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging.
    Jang HJ; Choi SH; Choi SJ; Choi WM; Byun JH; Won HJ; Shin YM
    Eur Radiol; 2023 Aug; 33(8):5792-5800. PubMed ID: 37017700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Youn SY; Kim B; Kim DH; Choi HJ; Sung PS; Choi JI
    Eur Radiol; 2022 Sep; 32(9):6270-6280. PubMed ID: 35348864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
    Min JH; Kim SH; Hwang JA; Hyun SH; Ha SY; Choi SY; Kim SW; Kim HS
    Eur Radiol; 2021 Jun; 31(6):3649-3660. PubMed ID: 33211142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.
    Kim SS; Lee S; Kim MJ
    Eur Radiol; 2021 May; 31(5):3405-3416. PubMed ID: 33146795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CK19 Predicts Recurrence and Prognosis of HBV Positive HCC.
    Shuyao W; Mingyang B; Feifei M; Xiaoqin H
    J Gastrointest Surg; 2022 Feb; 26(2):341-351. PubMed ID: 34506016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Cannella R; Matteini F; Dioguardi Burgio M; Sartoris R; Beaufrère A; Calderaro J; Mulé S; Reizine E; Luciani A; Laurent A; Seror O; Ganne-Carrié N; Wagner M; Scatton O; Vilgrain V; Cauchy F; Hobeika C; Ronot M
    Radiology; 2024 Feb; 310(2):e231160. PubMed ID: 38411519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study.
    Yoon JH; Choi SK; Cho SB; Kim HJ; Ko YS; Jun CH
    World J Gastroenterol; 2022 Sep; 28(36):5351-5363. PubMed ID: 36185633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients.
    Huang Z; Zhou P; Li S; Li K
    Ultrasound Med Biol; 2021 May; 47(5):1244-1252. PubMed ID: 33610338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariate model based on gadoxetic acid-enhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dual‑phenotype hepatocellular carcinoma.
    Liu MT; Zhang JY; Xu L; Qu Q; Lu MT; Jiang JF; Zhao XC; Zhang XQ; Zhang T
    Radiol Med; 2023 Nov; 128(11):1333-1346. PubMed ID: 37740839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.